Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2004;35:826-830
Published online before print February 26, 2004, doi: 10.1161/01.STR.0000119382.25543.2A
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
35/4/826    most recent
01.STR.0000119382.25543.2Av1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johansson, L.
Right arrow Articles by Boman, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johansson, L.
Right arrow Articles by Boman, K.
Related Collections
Right arrow Fibrinolysis
Right arrow Coagulation
Right arrow Acute Cerebral Hemorrhage

(Stroke. 2004;35:826.)
© 2004 American Heart Association, Inc.


Original Contributions

Hemostatic Factors as Risk Markers for Intracerebral Hemorrhage

A Prospective Incident Case-Referent Study

Lars Johansson, MD, PhD; Jan-Håkan Jansson, MD, PhD; Birgitta Stegmayr, PhD; Torbjörn K. Nilsson, MD, PhD; Göran Hallmans, MD, PhD Kurt Boman, MD, PhD

From the Department of Medicine, Skellefteå County Hospital, Skellefteå (L.J., J.-H.J., K.B.); Department of Public Health and Clinical Medicine (B.S., G.H.) and Medical Bank (G.H.), Umeå University Hospital, Umeå; and Department of Clinical Chemistry, Örebro University Hospital and Division of Biomedicine, Örebro University, Örebro (T.K.N.), Sweden.

Correspondence to Lars Johansson, Department of Medicine, Skellefteå County Hospital, Skellefteå, S-931 86 Sweden. E-mail lars.johansson.ss{at}vll.se

Background and Purpose— Abnormalities in the hemostatic system may cause hemorrhagic complications. The aim of the present study was to examine whether total concentrations of tissue plasminogen activator (tPA), plasminogen inhibitor-1 (PAI-1), tPA/PAI-1 complex, von Willebrand factor (VWF), and soluble thrombomodulin were associated with a first-ever intracerebral hemorrhage (ICH).

Methods— This prospective study was an incident case-referent study nested within the Västerbotten Intervention Program and the Northern Sweden Monitoring Trends and Determinants in Cardiovascular Disease (MONICA) cohorts. By 2000, {approx}74 000 subjects had been screened, and 39 ICH cases were defined according to the World Health Organization MONICA criteria. A total of 78 matched controls were selected from the same cohort.

Results— The average time from screening to the ICH event was 5.1 years. tPA/PAI-1 complex, systolic and diastolic blood pressures, and hypertension were associated with ICH in the univariate analysis. In the multivariate model, only hypertension (odds ratio [OR], 3.96; 95% confidence interval [CI], 1.27 to 12.36) and the tertile with the highest level of VWF compared with the lowest tertile (OR, 0.27; 95% CI, 0.08 to 0.90) were independently associated with ICH. The OR for the combined exposure to hypertension and low levels of VWF was 8.95, indicating a possible synergistic interaction. No associations were observed for smoking, cholesterol, body mass index, PAI-1, tPA, and soluble thrombomodulin.

Conclusions— This study showed that hypertension and low concentrations of VWF were independently associated with ICH. Furthermore, we observed a possible synergistic interaction between low levels of VWF and hypertension, suggesting 2 different pathways in the development of ICH.


Key Words: cerebral hemorrhage • fibrinolysis • risk factors • thrombomodulin • von Willebrand factor




This article has been cited by other articles:


Home page
StrokeHome page
J. D. Sturgeon, A. R. Folsom, W.T. Longstreth Jr, E. Shahar, W. D. Rosamond, and M. Cushman
Hemostatic and Inflammatory Risk Factors for Intracerebral Hemorrhage in a Pooled Cohort
Stroke, August 1, 2008; 39(8): 2268 - 2273.
[Abstract] [Full Text] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
Wei Hsi Chen, Hung Sheng Lin, and Y.-F. Kao
Type II Cryoglobulinemia and Brain Hemorrhage
Clinical and Applied Thrombosis/Hemostasis, April 1, 2008; 14(2): 241 - 244.
[Abstract] [PDF]


Home page
StrokeHome page
S. Nilsson-Ardnor, P.-G. Wiklund, P. Lindgren, A. K. Nilsson, T. Janunger, S. A. Escher, B. Hallbeck, B. Stegmayr, K. Asplund, and D. Holmberg
Linkage of Ischemic Stroke to the PDE4D Region on 5q in a Swedish Population
Stroke, August 1, 2005; 36(8): 1666 - 1671.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
D. Hanley and W. Hacke
Critical Care and Emergency Medicine Neurology in Stroke
Stroke, February 1, 2005; 36(2): 205 - 207.
[Full Text] [PDF]


Home page
Evid. Based Med.Home page
Other articles noted
Evid. Based Med., September 1, 2004; 9(5): e5 - e5.
[Full Text] [PDF]